DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUPS, MULTICENTER STUDY OF TOLCAPONE (TASMAR(R)) IN PARKINSONS-DISEASE PATIENTS WITH SINEMET(R)-INDUCED END-OF-DOSE WEARING-OFF
Ch. Adler et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUPS, MULTICENTER STUDY OF TOLCAPONE (TASMAR(R)) IN PARKINSONS-DISEASE PATIENTS WITH SINEMET(R)-INDUCED END-OF-DOSE WEARING-OFF, Neurology, 48(3), 1997, pp. 2006-2006